{
  "schema_version": "2.0",
  "doc_id": "06622a35a6789bcf22cd7b982177703c9464bb7fd079b9ba8dc15420ad133e7c",
  "extracted_at": "2026-02-01T08:55:57.498679+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "Indication",
      "name": "Addictive Disorders",
      "attributes": {
        "context": "Neurobiology of Addictive Disorders"
      },
      "source_chunk_ids": [
        "94365409e9610e8e08fbe59c0b9a7e96"
      ]
    },
    {
      "id": "ent_002",
      "type": "Indication",
      "name": "Drug Abuse",
      "attributes": {
        "context": "National Institute on Drug Abuse"
      },
      "source_chunk_ids": [
        "94365409e9610e8e08fbe59c0b9a7e96"
      ]
    },
    {
      "id": "ent_003",
      "type": "Indication",
      "name": "Drug addiction",
      "attributes": {
        "context": "Drug addiction is a chronically relapsing disorder"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_004",
      "type": "PharmEffect",
      "name": "compulsion",
      "attributes": {
        "context": "compulsion to seek and take the drug"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_005",
      "type": "PharmEffect",
      "name": "loss of control",
      "attributes": {
        "context": "loss of control in limiting intake"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_006",
      "type": "PharmEffect",
      "name": "negative emotional state",
      "attributes": {
        "context": "emergence of a negative emotional state"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_007",
      "type": "PharmEffect",
      "name": "dysphoria",
      "attributes": {
        "context": "eg, dysphoria, anxiety, irritability"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_008",
      "type": "PharmEffect",
      "name": "anxiety",
      "attributes": {
        "context": "eg, dysphoria, anxiety, irritability"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_009",
      "type": "PharmEffect",
      "name": "irritability",
      "attributes": {
        "context": "eg, dysphoria, anxiety, irritability"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_010",
      "type": "Indication",
      "name": "motivational withdrawal syndrome",
      "attributes": {
        "context": "reflecting a motivational withdrawal syndrome"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_011",
      "type": "PharmEffect",
      "name": "impulsivity",
      "attributes": {
        "context": "elements of both impulsivity and compulsivity"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_012",
      "type": "PharmEffect",
      "name": "compulsivity",
      "attributes": {
        "context": "elements of both impulsivity and compulsivity"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_013",
      "type": "Indication",
      "name": "addiction cycle",
      "attributes": {
        "context": "a composite addiction cycle"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_014",
      "type": "PharmEffect",
      "name": "binge/intoxication",
      "attributes": {
        "context": "three stages: 'binge/intoxication'"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_015",
      "type": "PharmEffect",
      "name": "withdrawal/negative affect",
      "attributes": {
        "context": "'withdrawal/negative affect'"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_016",
      "type": "PharmEffect",
      "name": "preoccupation/anticipation",
      "attributes": {
        "context": "'preoccupation/anticipation'"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_017",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "(craving)"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_018",
      "type": "PharmEffect",
      "name": "disrupted inhibitory control",
      "attributes": {
        "context": "in disrupted inhibitory control"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_019",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "The transition to addiction"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_020",
      "type": "PharmEffect",
      "name": "neuroplasticity",
      "attributes": {
        "context": "involves neuroplasticity"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_021",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "mesolimbic dopamine system"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_022",
      "type": "PharmEffect",
      "name": "neuroadaptations",
      "attributes": {
        "context": "a cascade of neuroadaptations"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_023",
      "type": "PharmEffect",
      "name": "dysregulation",
      "attributes": {
        "context": "eventually dysregulation of the prefrontal cortex"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_024",
      "type": "Indication",
      "name": "addiction syndrome",
      "attributes": {
        "context": "the addiction syndrome"
      },
      "source_chunk_ids": [
        "7ec3c94dfad1616c3e5245ed2a978d86"
      ]
    },
    {
      "id": "ent_025",
      "type": "Indication",
      "name": "substance dependence",
      "attributes": {
        "context": "going on to substance dependence on illicit drugs"
      },
      "source_chunk_ids": [
        "ab5adff416c8d1eb824bdeb2aa3eae9f"
      ]
    },
    {
      "id": "ent_026",
      "type": "Compound",
      "name": "ethanol",
      "attributes": {
        "context": "For alcohol"
      },
      "source_chunk_ids": [
        "ab5adff416c8d1eb824bdeb2aa3eae9f"
      ]
    },
    {
      "id": "ent_027",
      "type": "Indication",
      "name": "Substance Abuse or Dependence on Alcohol",
      "attributes": {
        "context": "met the criteria for Substance Abuse or Dependence on Alcohol"
      },
      "source_chunk_ids": [
        "ab5adff416c8d1eb824bdeb2aa3eae9f"
      ]
    },
    {
      "id": "ent_028",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "For nicotine"
      },
      "source_chunk_ids": [
        "ab5adff416c8d1eb824bdeb2aa3eae9f"
      ]
    },
    {
      "id": "ent_029",
      "type": "Taxon",
      "name": "Nicotiana",
      "attributes": {
        "context": "users of a tobacco product"
      },
      "source_chunk_ids": [
        "ab5adff416c8d1eb824bdeb2aa3eae9f"
      ]
    },
    {
      "id": "ent_030",
      "type": "Compound",
      "name": "opioids",
      "attributes": {
        "context": "opioids and alcohol have been shown to be directly self-administered"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_031",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "opioids and alcohol have been shown to be directly self-administered"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_032",
      "type": "PharmEffect",
      "name": "self-administered",
      "attributes": {
        "context": "have been shown to be directly self-administered into the VTA"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_033",
      "type": "PharmEffect",
      "name": "place conditioning",
      "attributes": {
        "context": "intracranial place conditioning"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_034",
      "type": "Compound",
      "name": "Opioids",
      "attributes": {
        "context": "Opioids also produce conditioned place preference"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_035",
      "type": "PharmEffect",
      "name": "conditioned place preference",
      "attributes": {
        "context": "produce conditioned place preference when injected into the VTA"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_036",
      "type": "Compound",
      "name": "Opioids",
      "attributes": {
        "context": "Opioids, phencyclidine, and psychostimulants are directly self-administered"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_037",
      "type": "Compound",
      "name": "phencyclidine",
      "attributes": {
        "context": "phencyclidine, and psychostimulants are directly self-administered"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_038",
      "type": "Compound",
      "name": "psychostimulants",
      "attributes": {
        "context": "psychostimulants are directly self-administered into the nucleus accumbens"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_039",
      "type": "PharmEffect",
      "name": "self-administered",
      "attributes": {
        "context": "are directly self-administered into the nucleus accumbens"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_040",
      "type": "Compound",
      "name": "psychostimulants",
      "attributes": {
        "context": "psychostimulants produce a conditioned place preference"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_041",
      "type": "PharmEffect",
      "name": "conditioned place preference",
      "attributes": {
        "context": "produce a conditioned place preference when injected into the nucleus accumbens"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_042",
      "type": "Compound",
      "name": "Cocaine",
      "attributes": {
        "context": "Cocaine and phencyclidine are directly self-administered"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_043",
      "type": "Compound",
      "name": "phencyclidine",
      "attributes": {
        "context": "Cocaine and phencyclidine are directly self-administered"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_044",
      "type": "PharmEffect",
      "name": "self-administered",
      "attributes": {
        "context": "are directly self-administered into the frontal cortex"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_045",
      "type": "PharmEffect",
      "name": "activated",
      "attributes": {
        "context": "system is activated by acute administration"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_046",
      "type": "Compound",
      "name": "opioids",
      "attributes": {
        "context": "administration of opioids, ethanol, nicotine, and \\Delta^9-THC"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_047",
      "type": "Compound",
      "name": "ethanol",
      "attributes": {
        "context": "administration of opioids, ethanol, nicotine, and \\Delta^9-THC"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_048",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "administration of opioids, ethanol, nicotine, and \\Delta^9-THC"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_049",
      "type": "Compound",
      "name": "\\Delta^9-THC",
      "attributes": {
        "context": "administration of opioids, ethanol, nicotine, and \\Delta^9-THC"
      },
      "source_chunk_ids": [
        "ddf164a4072cb74780764f32be06eac7"
      ]
    },
    {
      "id": "ent_050",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "Intravenous nicotine self-administration"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_051",
      "type": "PharmEffect",
      "name": "self-administration",
      "attributes": {
        "context": "nicotine self-administration"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_052",
      "type": "PharmEffect",
      "name": "blocked",
      "attributes": {
        "context": "self-administration is blocked"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_053",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "mesocorticolimbic dopamine system"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_054",
      "type": "PharmEffect",
      "name": "receptor activation",
      "attributes": {
        "context": "nicotinic receptor activation"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_055",
      "type": "PharmEffect",
      "name": "release",
      "attributes": {
        "context": "activation of release of dopamine"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_056",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "release of dopamine"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_057",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "nicotine reward"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_058",
      "type": "PharmEffect",
      "name": "reward",
      "attributes": {
        "context": "nicotine reward"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_059",
      "type": "PharmEffect",
      "name": "conditioned place preference",
      "attributes": {
        "context": "measured by conditioned place preference"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_060",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "mesocorticolimbic dopamine system"
      },
      "source_chunk_ids": [
        "117bbf153ab077ce99f6a7a757199870"
      ]
    },
    {
      "id": "ent_061",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine receptor blockade"
      },
      "source_chunk_ids": [
        "4d4d9342ba49face27f929dfd0ee10b9"
      ]
    },
    {
      "id": "ent_062",
      "type": "PharmEffect",
      "name": "receptor blockade",
      "attributes": {
        "context": "dopamine receptor blockade"
      },
      "source_chunk_ids": [
        "4d4d9342ba49face27f929dfd0ee10b9"
      ]
    },
    {
      "id": "ent_063",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "decreased cocaine-seeking"
      },
      "source_chunk_ids": [
        "4d4d9342ba49face27f929dfd0ee10b9"
      ]
    },
    {
      "id": "ent_064",
      "type": "PharmEffect",
      "name": "cocaine-seeking",
      "attributes": {
        "context": "decreased cocaine-seeking"
      },
      "source_chunk_ids": [
        "4d4d9342ba49face27f929dfd0ee10b9"
      ]
    },
    {
      "id": "ent_065",
      "type": "PharmEffect",
      "name": "reinforcing effects",
      "attributes": {
        "context": "acute reinforcing effects"
      },
      "source_chunk_ids": [
        "4d4d9342ba49face27f929dfd0ee10b9"
      ]
    },
    {
      "id": "ent_066",
      "type": "Compound",
      "name": "psychostimulant drugs",
      "attributes": {
        "context": "psychostimulant drugs"
      },
      "source_chunk_ids": [
        "4d4d9342ba49face27f929dfd0ee10b9"
      ]
    },
    {
      "id": "ent_067",
      "type": "Indication",
      "name": "compulsive use",
      "attributes": {
        "context": "transition to compulsive use"
      },
      "source_chunk_ids": [
        "4d4d9342ba49face27f929dfd0ee10b9"
      ]
    },
    {
      "id": "ent_068",
      "type": "PharmEffect",
      "name": "drug reward",
      "attributes": {
        "context": "neurobiological circuit for drug reward"
      },
      "source_chunk_ids": [
        "28bf4fd61eb48af2e0d2ed048ca2bbed"
      ]
    },
    {
      "id": "ent_069",
      "type": "Compound",
      "name": "monoamine",
      "attributes": {
        "context": "ascending monoamine pathways"
      },
      "source_chunk_ids": [
        "28bf4fd61eb48af2e0d2ed048ca2bbed"
      ]
    },
    {
      "id": "ent_070",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "mesocorticolimbic dopamine system"
      },
      "source_chunk_ids": [
        "28bf4fd61eb48af2e0d2ed048ca2bbed"
      ]
    },
    {
      "id": "ent_071",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine release"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_072",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "for cocaine"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_073",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {
        "context": "amphetamine"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_074",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "and nicotine"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_075",
      "type": "Compound",
      "name": "opioid peptide",
      "attributes": {
        "context": "opioid peptide receptor activation"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_076",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine activation"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_077",
      "type": "Compound",
      "name": "opiates",
      "attributes": {
        "context": "for opiates"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_078",
      "type": "Compound",
      "name": "GABA_A",
      "attributes": {
        "context": "GABA_A systems"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_079",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "for alcohol"
      },
      "source_chunk_ids": [
        "2b1057e2521dd157f95490262a3d7de8"
      ]
    },
    {
      "id": "ent_080",
      "type": "PharmEffect",
      "name": "reinforcing effects",
      "attributes": {
        "context": "acute reinforcing effects of drugs"
      },
      "source_chunk_ids": [
        "1768e52b86f3b9f09db381276afdfc4d"
      ]
    },
    {
      "id": "ent_081",
      "type": "Compound",
      "name": "dynorphin",
      "attributes": {
        "context": "dynorphin is increased"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_082",
      "type": "PharmEffect",
      "name": "aversive effects",
      "attributes": {
        "context": "aversive effects of drug withdrawal"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_083",
      "type": "PharmEffect",
      "name": "drug withdrawal",
      "attributes": {
        "context": "aversive effects of drug withdrawal"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_084",
      "type": "PharmEffect",
      "name": "dopaminergic activation",
      "attributes": {
        "context": "dopaminergic activation"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_085",
      "type": "PharmEffect",
      "name": "decrease dopaminergic function",
      "attributes": {
        "context": "decrease dopaminergic function"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_086",
      "type": "Compound",
      "name": "\\kappa-Opioid agonists",
      "attributes": {
        "context": "\\kappa-Opioid agonists are aversive"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_087",
      "type": "PharmEffect",
      "name": "aversive",
      "attributes": {
        "context": "\\kappa-Opioid agonists are aversive"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_088",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "cocaine, opioid, and ethanol withdrawal"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_089",
      "type": "Compound",
      "name": "opioid",
      "attributes": {
        "context": "cocaine, opioid, and ethanol withdrawal"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_090",
      "type": "Compound",
      "name": "ethanol",
      "attributes": {
        "context": "cocaine, opioid, and ethanol withdrawal"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_091",
      "type": "PharmEffect",
      "name": "withdrawal",
      "attributes": {
        "context": "ethanol withdrawal is associated"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_092",
      "type": "Compound",
      "name": "dynorphin",
      "attributes": {
        "context": "increased dynorphin"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_093",
      "type": "Compound",
      "name": "salvidorin A",
      "attributes": {
        "context": "salvidorin A, which is a \\kappa-agonist"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_094",
      "type": "Compound",
      "name": "\\kappa-agonist",
      "attributes": {
        "context": "which is a \\kappa-agonist"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_095",
      "type": "PharmEffect",
      "name": "hallucinogenic effects",
      "attributes": {
        "context": "hallucinogenic effects"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_096",
      "type": "PharmEffect",
      "name": "pleasurable properties",
      "attributes": {
        "context": "pleasurable properties"
      },
      "source_chunk_ids": [
        "8e1bf91c9f68871cec9558b8b5ebe0ad"
      ]
    },
    {
      "id": "ent_097",
      "type": "Compound",
      "name": "Glutamate",
      "attributes": {
        "context": "a glutamatergic pathway"
      },
      "source_chunk_ids": [
        "2c9ff6e393e262124ccb638bae826e3b"
      ]
    },
    {
      "id": "ent_098",
      "type": "Compound",
      "name": "Dopamine",
      "attributes": {
        "context": "the dopamine projection"
      },
      "source_chunk_ids": [
        "2c9ff6e393e262124ccb638bae826e3b"
      ]
    },
    {
      "id": "ent_099",
      "type": "Compound",
      "name": "Gamma-aminobutyric acid",
      "attributes": {
        "context": "the GABA projection"
      },
      "source_chunk_ids": [
        "2c9ff6e393e262124ccb638bae826e3b"
      ]
    },
    {
      "id": "ent_100",
      "type": "Compound",
      "name": "Corticotropin-releasing factor",
      "attributes": {
        "context": "activation of both CRF and norepinephrine"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_101",
      "type": "Compound",
      "name": "norepinephrine",
      "attributes": {
        "context": "activation of both CRF and norepinephrine"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_102",
      "type": "PharmEffect",
      "name": "stress-induced reinstatement of drug-related responding",
      "attributes": {
        "context": "stress-induced reinstatement of drug-related responding in animal models"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_103",
      "type": "PharmEffect",
      "name": "drug-related responding",
      "attributes": {
        "context": "stress-induced reinstatement of drug-related responding"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_104",
      "type": "Indication",
      "name": "Protracted abstinence",
      "attributes": {
        "context": "Protracted abstinence, largely described in alcohol dependence models"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_105",
      "type": "Indication",
      "name": "alcohol dependence",
      "attributes": {
        "context": "largely described in alcohol dependence models"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_106",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "overactive glutamatergic and CRF systems"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_107",
      "type": "Compound",
      "name": "Corticotropin-releasing factor",
      "attributes": {
        "context": "overactive glutamatergic and CRF systems"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_108",
      "type": "PharmEffect",
      "name": "overactive glutamatergic and Corticotropin-releasing factor systems",
      "attributes": {
        "context": "appears to involve overactive glutamatergic and CRF systems"
      },
      "source_chunk_ids": [
        "da862fd2f30135e181d86a3648c72e88"
      ]
    },
    {
      "id": "ent_109",
      "type": "Indication",
      "name": "cocaine addiction",
      "attributes": {
        "context": "Human subjects with cocaine addiction show impaired performance"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_110",
      "type": "PharmEffect",
      "name": "impaired performance",
      "attributes": {
        "context": "show impaired performance in tasks involving attention"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_111",
      "type": "PharmEffect",
      "name": "attention",
      "attributes": {
        "context": "tasks involving attention, cognitive flexibility"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_112",
      "type": "PharmEffect",
      "name": "cognitive flexibility",
      "attributes": {
        "context": "attention, cognitive flexibility, and delayed reward discounting"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_113",
      "type": "PharmEffect",
      "name": "delayed reward discounting",
      "attributes": {
        "context": "cognitive flexibility, and delayed reward discounting"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_114",
      "type": "PharmEffect",
      "name": "spatial memory impairments",
      "attributes": {
        "context": "spatial, verbal, and recognition memory impairments"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_115",
      "type": "PharmEffect",
      "name": "verbal memory impairments",
      "attributes": {
        "context": "verbal, and recognition memory impairments"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_116",
      "type": "PharmEffect",
      "name": "recognition memory impairments",
      "attributes": {
        "context": "recognition memory impairments that are mediated by the hippocampus"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_117",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "in addiction using animal models"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_118",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "Experimenter-administered cocaine produced impairments in reversal learning"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_119",
      "type": "PharmEffect",
      "name": "impairments in reversal learning",
      "attributes": {
        "context": "cocaine produced impairments in reversal learning"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_120",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "access, but not limited access, to cocaine showed deficits"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_121",
      "type": "PharmEffect",
      "name": "deficits in working memory",
      "attributes": {
        "context": "cocaine showed deficits in working memory"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_122",
      "type": "PharmEffect",
      "name": "sustained attention task",
      "attributes": {
        "context": "sustained attention task (a prefrontal-cortex-dependent task)"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_123",
      "type": "PharmEffect",
      "name": "object recognition task",
      "attributes": {
        "context": "an object recognition task (a hippocampus-dependent task)"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_124",
      "type": "Compound",
      "name": "dopamine D2 receptor mRNA",
      "attributes": {
        "context": "decrease in dopamine D2 receptor mRNA in the medial and orbital prefrontal cortices"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_125",
      "type": "PharmEffect",
      "name": "decrease in dopamine D2 receptor mRNA",
      "attributes": {
        "context": "associated with a significant decrease in dopamine D2 receptor mRNA"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_126",
      "type": "Indication",
      "name": "cocaine addiction",
      "attributes": {
        "context": "associated with human cocaine addiction"
      },
      "source_chunk_ids": [
        "1500a56b07081743dcb71ac8cde2b5de"
      ]
    },
    {
      "id": "ent_127",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "brain pharmacokinetics of cocaine"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_128",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {
        "context": "cocaine and of methamphetamine"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_129",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "cocaine is taken every 30\u201360 min"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_130",
      "type": "Concentration",
      "name": "every 30\u201360 min",
      "attributes": {
        "context": "taken every 30\u201360 min"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_131",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {
        "context": "methamphetamine is taken every couple of hours"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_132",
      "type": "Concentration",
      "name": "every couple of hours",
      "attributes": {
        "context": "taken every couple of hours"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_133",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "exception of alcohol"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_134",
      "type": "PharmEffect",
      "name": "stimulant",
      "attributes": {
        "context": "stimulant drugs such as methylphenidate"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_135",
      "type": "Compound",
      "name": "methylphenidate",
      "attributes": {
        "context": "drugs such as methylphenidate"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_136",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {
        "context": "methylphenidate or amphetamine"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_137",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "increase dopamine"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_138",
      "type": "PharmEffect",
      "name": "reinforcing",
      "attributes": {
        "context": "not typically perceived as reinforcing"
      },
      "source_chunk_ids": [
        "2cc5e978fc99bb1c86c08df35cdff211"
      ]
    },
    {
      "id": "ent_139",
      "type": "PharmEffect",
      "name": "rewarding responses",
      "attributes": {
        "context": "influences the rewarding responses to drugs"
      },
      "source_chunk_ids": [
        "5306ee2ba9d1c0b59cc704e1a734a3e2"
      ]
    },
    {
      "id": "ent_140",
      "type": "PharmEffect",
      "name": "brain activation response",
      "attributes": {
        "context": "regional brain activation response of the brain"
      },
      "source_chunk_ids": [
        "5306ee2ba9d1c0b59cc704e1a734a3e2"
      ]
    },
    {
      "id": "ent_141",
      "type": "PharmEffect",
      "name": "rewarding effects",
      "attributes": {
        "context": "dependency of the drug's rewarding effects"
      },
      "source_chunk_ids": [
        "5306ee2ba9d1c0b59cc704e1a734a3e2"
      ]
    },
    {
      "id": "ent_142",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "neurotransmitters such as glutamate"
      },
      "source_chunk_ids": [
        "5306ee2ba9d1c0b59cc704e1a734a3e2"
      ]
    },
    {
      "id": "ent_143",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "reactivity of dopamine cells and dopamine release"
      },
      "source_chunk_ids": [
        "5306ee2ba9d1c0b59cc704e1a734a3e2"
      ]
    },
    {
      "id": "ent_144",
      "type": "PharmEffect",
      "name": "dopamine release",
      "attributes": {
        "context": "dopamine release in the nucleus accumbens"
      },
      "source_chunk_ids": [
        "5306ee2ba9d1c0b59cc704e1a734a3e2"
      ]
    },
    {
      "id": "ent_145",
      "type": "PharmEffect",
      "name": "drug intoxication",
      "attributes": {
        "context": "stage of drug intoxication"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_146",
      "type": "Indication",
      "name": "abuse",
      "attributes": {
        "context": "frequency of its abuse"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_147",
      "type": "Compound",
      "name": "opiates",
      "attributes": {
        "context": "such as opiates"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_148",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "opiates, alcohol"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_149",
      "type": "Compound",
      "name": "sedative hypnotics",
      "attributes": {
        "context": "and sedative hypnotics"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_150",
      "type": "PharmEffect",
      "name": "drug discontinuation",
      "attributes": {
        "context": "drug discontinuation in chronic drug users"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_151",
      "type": "Indication",
      "name": "chronic drug users",
      "attributes": {
        "context": "in chronic drug users"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_152",
      "type": "Indication",
      "name": "physical withdrawal syndrome",
      "attributes": {
        "context": "acute physical withdrawal syndrome"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_153",
      "type": "PharmEffect",
      "name": "fatal",
      "attributes": {
        "context": "can sometimes be fatal"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_154",
      "type": "Indication",
      "name": "motivational withdrawal syndrome",
      "attributes": {
        "context": "a motivational withdrawal syndrome"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_155",
      "type": "Indication",
      "name": "dysphoria",
      "attributes": {
        "context": "characterized by dysphoria"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_156",
      "type": "Indication",
      "name": "irritability",
      "attributes": {
        "context": "dysphoria, irritability"
      },
      "source_chunk_ids": [
        "2af7262737a569dfca2e056ceca8e199"
      ]
    },
    {
      "id": "ent_157",
      "type": "Indication",
      "name": "distress",
      "attributes": {
        "context": "distress, and sleep disturbances"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_158",
      "type": "Indication",
      "name": "sleep disturbances",
      "attributes": {
        "context": "sleep disturbances that persist"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_159",
      "type": "Indication",
      "name": "withdrawal",
      "attributes": {
        "context": "protracted withdrawal"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_160",
      "type": "Indication",
      "name": "withdrawal",
      "attributes": {
        "context": "acute withdrawal"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_161",
      "type": "Indication",
      "name": "withdrawal",
      "attributes": {
        "context": "motivational withdrawal"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_162",
      "type": "Indication",
      "name": "relapse",
      "attributes": {
        "context": "contribute to relapse"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_163",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "changes in dopamine"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_164",
      "type": "Compound",
      "name": "heroin",
      "attributes": {
        "context": "during heroin withdrawal"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_165",
      "type": "Indication",
      "name": "withdrawal",
      "attributes": {
        "context": "heroin withdrawal"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_166",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine decreases"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_167",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "striatal dopamine"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_168",
      "type": "Indication",
      "name": "heroin addiction",
      "attributes": {
        "context": "in heroin abusers"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_169",
      "type": "Compound",
      "name": "heroin",
      "attributes": {
        "context": "in heroin abusers"
      },
      "source_chunk_ids": [
        "d23e3a683994b0e3cad1690e71c57e2d"
      ]
    },
    {
      "id": "ent_170",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "development of addiction"
      },
      "source_chunk_ids": [
        "23dd0d8e3bcac33036eef16a9e444644"
      ]
    },
    {
      "id": "ent_171",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "stages of the addiction cycle"
      },
      "source_chunk_ids": [
        "23dd0d8e3bcac33036eef16a9e444644"
      ]
    },
    {
      "id": "ent_172",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "mesolimbic dopamine system"
      },
      "source_chunk_ids": [
        "23dd0d8e3bcac33036eef16a9e444644"
      ]
    },
    {
      "id": "ent_173",
      "type": "Compound",
      "name": "Dopamine",
      "attributes": {
        "context": "Mesolimbic Dopamine System"
      },
      "source_chunk_ids": [
        "2e3c1abc58ff11b6fc7fdc770cc4870d"
      ]
    },
    {
      "id": "ent_174",
      "type": "PharmEffect",
      "name": "Compulsivity \u2013 loss of control",
      "attributes": {
        "context": "'Compulsivity \u2013 loss of control'"
      },
      "source_chunk_ids": [
        "19b00f35404621b65e932f8c9480849e"
      ]
    },
    {
      "id": "ent_175",
      "type": "Compound",
      "name": "Dopamine",
      "attributes": {
        "context": "'Mesolimbic DA'"
      },
      "source_chunk_ids": [
        "19b00f35404621b65e932f8c9480849e"
      ]
    },
    {
      "id": "ent_176",
      "type": "PharmEffect",
      "name": "behavioral sensitization",
      "attributes": {
        "context": "showed behavioral sensitization"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_177",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "cocaine-sensitized mice"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_178",
      "type": "PharmEffect",
      "name": "enhancement of LTP",
      "attributes": {
        "context": "showed an enhancement of LTP"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_179",
      "type": "PharmEffect",
      "name": "glutamatergic activity",
      "attributes": {
        "context": "increased activity of glutamatergic activity"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_180",
      "type": "PharmEffect",
      "name": "withdrawal",
      "attributes": {
        "context": "during withdrawal"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_181",
      "type": "Compound",
      "name": "glutamate-1 receptors (GluR1)",
      "attributes": {
        "context": "ratio of glutamate-1 receptors (GluR1)"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_182",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "last injection of cocaine"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_183",
      "type": "Compound",
      "name": "AMPA receptors",
      "attributes": {
        "context": "redistribution of AMPA receptors"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_184",
      "type": "Compound",
      "name": "GluR2",
      "attributes": {
        "context": "lacking GluR2"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_185",
      "type": "Compound",
      "name": "AMPA receptors",
      "attributes": {
        "context": "cell-surface AMPA receptors"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_186",
      "type": "Compound",
      "name": "dopamine D_1 receptors",
      "attributes": {
        "context": "activation of dopamine D_1 receptors"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_187",
      "type": "Compound",
      "name": "protein kinase A",
      "attributes": {
        "context": "subsequent protein kinase A signaling"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_188",
      "type": "Compound",
      "name": "GluR1",
      "attributes": {
        "context": "overexpression of GluR1"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_189",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "extinction of cocaine-seeking responses"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_190",
      "type": "PharmEffect",
      "name": "extinction of cocaine-seeking responses",
      "attributes": {
        "context": "facilitated extinction of cocaine-seeking responses"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_191",
      "type": "PharmEffect",
      "name": "increased brain stimulation reward thresholds",
      "attributes": {
        "context": "increased brain stimulation reward thresholds"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_192",
      "type": "PharmEffect",
      "name": "decreased reward",
      "attributes": {
        "context": "reflecting decreased reward"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_193",
      "type": "PharmEffect",
      "name": "decreased motivated behavior",
      "attributes": {
        "context": "decreased motivated behavior"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_194",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "reexposure to cocaine"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_195",
      "type": "PharmEffect",
      "name": "withdrawal",
      "attributes": {
        "context": "during extended withdrawal"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_196",
      "type": "PharmEffect",
      "name": "synaptic depression",
      "attributes": {
        "context": "produced synaptic depression"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_197",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "enhanced glutamate release"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_198",
      "type": "Compound",
      "name": "AMPA receptor",
      "attributes": {
        "context": "increase in AMPA receptor expression"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_199",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "observed with cocaine"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_200",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {
        "context": "in amphetamine-sensitized rats"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_201",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "effects of glutamate projections"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_202",
      "type": "PharmEffect",
      "name": "cocaine withdrawal",
      "attributes": {
        "context": "during cocaine vs amphetamine withdrawal"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_203",
      "type": "PharmEffect",
      "name": "amphetamine withdrawal",
      "attributes": {
        "context": "cocaine vs amphetamine withdrawal"
      },
      "source_chunk_ids": [
        "6303d7810e975fc83e2c88f9d9b4f2eb"
      ]
    },
    {
      "id": "ent_204",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "compulsive cocaine use"
      },
      "source_chunk_ids": [
        "5e5a398ca7c46fdd910fcb172c7e4d67"
      ]
    },
    {
      "id": "ent_205",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "increased dopamine release"
      },
      "source_chunk_ids": [
        "5e5a398ca7c46fdd910fcb172c7e4d67"
      ]
    },
    {
      "id": "ent_206",
      "type": "PharmEffect",
      "name": "increased dopamine release",
      "attributes": {
        "context": "increased dopamine release in the dorsal striatum"
      },
      "source_chunk_ids": [
        "5e5a398ca7c46fdd910fcb172c7e4d67"
      ]
    },
    {
      "id": "ent_207",
      "type": "Indication",
      "name": "compulsive cocaine use",
      "attributes": {
        "context": "habitual compulsive cocaine use"
      },
      "source_chunk_ids": [
        "5e5a398ca7c46fdd910fcb172c7e4d67"
      ]
    },
    {
      "id": "ent_208",
      "type": "Indication",
      "name": "drug addiction",
      "attributes": {
        "context": "drug addiction represents changes"
      },
      "source_chunk_ids": [
        "5e5a398ca7c46fdd910fcb172c7e4d67"
      ]
    },
    {
      "id": "ent_209",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "striatal slow dopamine increases"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_210",
      "type": "Compound",
      "name": "methylphenidate",
      "attributes": {
        "context": "oral methylphenidate"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_211",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "do not elicit craving"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_212",
      "type": "Indication",
      "name": "cocaine abusers",
      "attributes": {
        "context": "in cocaine abusers"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_213",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "the craving results from"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_214",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "fast dopamine increases"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_215",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "phasic dopamine firing"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_216",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "slow dopamine increases"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_217",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "tonic dopamine firing"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_218",
      "type": "Compound",
      "name": "methylphenidate",
      "attributes": {
        "context": "oral methylphenidate"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_219",
      "type": "Compound",
      "name": "methylphenidate",
      "attributes": {
        "context": "intravenous administration of methylphenidate"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_220",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "fast dopamine increases"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_221",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "induces intense craving"
      },
      "source_chunk_ids": [
        "80d9ab58b63ff5ef34be7453932666a0"
      ]
    },
    {
      "id": "ent_222",
      "type": "Indication",
      "name": "drug-addicted",
      "attributes": {
        "context": "in drug-addicted subjects"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_223",
      "type": "PharmEffect",
      "name": "salience attribution",
      "attributes": {
        "context": "implicated in salience attribution"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_224",
      "type": "PharmEffect",
      "name": "motivation",
      "attributes": {
        "context": "salience attribution and motivation"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_225",
      "type": "PharmEffect",
      "name": "compulsivity",
      "attributes": {
        "context": "results in compulsivity"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_226",
      "type": "PharmEffect",
      "name": "inhibitory control",
      "attributes": {
        "context": "implicated in inhibitory control"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_227",
      "type": "PharmEffect",
      "name": "conflict resolution",
      "attributes": {
        "context": "inhibitory control and conflict resolution"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_228",
      "type": "PharmEffect",
      "name": "impulsivity",
      "attributes": {
        "context": "results in impulsivity"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_229",
      "type": "Indication",
      "name": "cocaine-addicted",
      "attributes": {
        "context": "in cocaine-addicted subjects"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_230",
      "type": "Compound",
      "name": "methylphenidate",
      "attributes": {
        "context": "administration of methylphenidate"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_231",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "similar to those of cocaine"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_232",
      "type": "PharmEffect",
      "name": "cocaine craving",
      "attributes": {
        "context": "associated with cocaine craving"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_233",
      "type": "Indication",
      "name": "marijuana-addicted",
      "attributes": {
        "context": "in marijuana-addicted subjects"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_234",
      "type": "Compound",
      "name": "\\Delta^9-THC",
      "attributes": {
        "context": "administration of \\Delta^9-THC"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_235",
      "type": "PharmEffect",
      "name": "reward",
      "attributes": {
        "context": "predict reward"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_236",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "trigger craving"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_237",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "regulate dopamine cell firing and release"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_238",
      "type": "PharmEffect",
      "name": "incentive motivational values",
      "attributes": {
        "context": "enhanced incentive motivational values"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_239",
      "type": "Indication",
      "name": "addicted individuals",
      "attributes": {
        "context": "drugs in addicted individuals"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_240",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine increases"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_241",
      "type": "Compound",
      "name": "glutamatergic",
      "attributes": {
        "context": "glutamatergic afferents"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_242",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "increases in dopamine"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_243",
      "type": "PharmEffect",
      "name": "compulsive drug consumption",
      "attributes": {
        "context": "contribute to the compulsive drug consumption"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_244",
      "type": "PharmEffect",
      "name": "drug bingeing",
      "attributes": {
        "context": "characterizes drug bingeing"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_245",
      "type": "Indication",
      "name": "addicted individuals",
      "attributes": {
        "context": "drug bingeing in addicted individuals"
      },
      "source_chunk_ids": [
        "df0ae8afc36f1751494dcf9eb5d4cf47"
      ]
    },
    {
      "id": "ent_246",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "striatal dopamine activity"
      },
      "source_chunk_ids": [
        "568526dedd0adac49f1f2e1d2b475833"
      ]
    },
    {
      "id": "ent_247",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine cell activity"
      },
      "source_chunk_ids": [
        "568526dedd0adac49f1f2e1d2b475833"
      ]
    },
    {
      "id": "ent_248",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "modulating dopamine increases"
      },
      "source_chunk_ids": [
        "568526dedd0adac49f1f2e1d2b475833"
      ]
    },
    {
      "id": "ent_249",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "in addicted individuals"
      },
      "source_chunk_ids": [
        "568526dedd0adac49f1f2e1d2b475833"
      ]
    },
    {
      "id": "ent_250",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "concomitant dopamine and glutamate neurotransmission"
      },
      "source_chunk_ids": [
        "cbbebfb84757c14da4c38cb13a772473"
      ]
    },
    {
      "id": "ent_251",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "concomitant dopamine and glutamate neurotransmission"
      },
      "source_chunk_ids": [
        "cbbebfb84757c14da4c38cb13a772473"
      ]
    },
    {
      "id": "ent_252",
      "type": "Indication",
      "name": "craving",
      "attributes": {
        "context": "involved in cue/context-dependent craving"
      },
      "source_chunk_ids": [
        "cbbebfb84757c14da4c38cb13a772473"
      ]
    },
    {
      "id": "ent_253",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "component of addiction"
      },
      "source_chunk_ids": [
        "cbbebfb84757c14da4c38cb13a772473"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:04.057344+00:00",
    "original_file": "entities.json"
  }
}